oxaprozin has been researched along with Hypertension in 3 studies
Oxaprozin: An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE.
oxaprozin : A monocarboxylic acid that is a propionic acid derivative having a 4,5-diphenyl-1,3-oxazol-2-yl substituent at position 3. It is non-steroidal anti-inflammatory drug commonly used to relieve the pain and inflammatory responses associated with osteoarthritis and rheumatoid arthritis.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Domestic (US) cases of apparently unconfounded, acute hypertension leading to hospitalisation were collected and reviewed from the spontaneous adverse events database of the FDA for rofecoxib, celecoxib, nabumetone and oxaprozin for the initial 3 years of marketing." | 7.72 | Spontaneous reports of hypertension leading to hospitalisation in association with rofecoxib, celecoxib, nabumetone and oxaprozin. ( Beitz, J; Bonnel, R; Brinker, A; Goldkind, L, 2004) |
| "Domestic (US) cases of apparently unconfounded, acute hypertension leading to hospitalisation were collected and reviewed from the spontaneous adverse events database of the FDA for rofecoxib, celecoxib, nabumetone and oxaprozin for the initial 3 years of marketing." | 3.72 | Spontaneous reports of hypertension leading to hospitalisation in association with rofecoxib, celecoxib, nabumetone and oxaprozin. ( Beitz, J; Bonnel, R; Brinker, A; Goldkind, L, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brinker, A | 1 |
| Goldkind, L | 1 |
| Bonnel, R | 1 |
| Beitz, J | 1 |
| Ogawa, M | 1 |
| Ueda, S | 1 |
| Hamano, Y | 1 |
| Ito, K | 1 |
| Saisho, H | 1 |
| Akikusa, B | 1 |
| Halabi, A | 1 |
| Linde, M | 1 |
| Zeidler, H | 1 |
| König, J | 1 |
| Kirch, W | 1 |
1 trial available for oxaprozin and Hypertension
| Article | Year |
|---|---|
Double-blind study on the interaction of oxaprozin with metoprolol in hypertensives.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Blood Pressure; Double-Blind Method | 1989 |
2 other studies available for oxaprozin and Hypertension
| Article | Year |
|---|---|
Spontaneous reports of hypertension leading to hospitalisation in association with rofecoxib, celecoxib, nabumetone and oxaprozin.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anti-Inflammatory Agents, N | 2004 |
Membranous nephropathy associated with oxaprozin treatment.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Back Pain; Capillaries; Complement C3; Edema; Epithe | 1996 |